Simvastatin reduces graft vessel disease and mortality after heart transplantation: a four-year randomized trial.
about
HMG CoA reductase inhibitors (statins) for kidney transplant recipientsStatins and fibrates for preventing melanomaWhat is the optimal prophylaxis for treatment of cardiac allograft vasculopathy?HMG-CoA reductase inhibition aborts functional differentiation and triggers apoptosis in cultured primary human monocytes: a potential mechanism of statin-mediated vasculoprotectionPositive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligoDo the pleiotropic effects of statins in the vasculature predict a role in inflammatory diseases?Clinical use of statins in hematopoietic stem cell transplantation: Old drugs and new horizonsCardiac allograft vasculopathy: diagnosis, therapy, and prognosis.Ongoing clinical trials of the pleiotropic effects of statinsTacrolimus/cerivastatin interaction study in liver transplant recipientsIn situ detection of tissue factor within the coronary intima in rat cardiac allograft vasculopathy.Transplant Coronary Vasculopathy.Is there an anti-inflammatory effect of statins in rheumatoid arthritis? Analysis of a large routinely collected claims databaseFluvastatin in combination with cyclosporin in renal transplant recipients: a review of clinical and safety experience.The metabolic effects of cyclosporin and tacrolimus.Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials.Weight gain and cardiovascular risk after organ transplantation.Can the potential benefits of statins in general medical practice be extrapolated to liver transplantation?Statins and renal function.Cardiovascular toxicities of immunosuppressive agents.The complex interplay between cholesterol and prostate malignancy.Graft vessel disease following heart transplantation: a systematic review of the role of statin therapy.Recombinant apolipoprotein A-I(Milano): a novel agent for the induction of regression of atherosclerotic plaques.Progression of cardiac allograft vascular disease as assessed by serial intravascular ultrasound: correlation to immunological and non-immunological risk factorsNoncholesterol-lowering effects of statins.Statins in solid organ transplantation: is there an immunosuppressive effect?Do statins offer therapeutic potential in inflammatory arthritis?Statins: immunomodulators for autoimmune rheumatic disease?Novel applications of statins for bone regenerationAnti-inflammatory effects of statins: clinical evidence and basic mechanisms.Statins and bone metabolism.Cardiac allograft vasculopathy: the Achilles' heel of long-term survival after cardiac transplantation.Statins and the acute coronary syndrome: 'the early bird catches the worm'.Drug insight: Immunomodulatory effects of statins--potential benefits for renal patients?Role of imaging end points in atherosclerosis trials: focus on intravascular ultrasound.Cardiac allograft vasculopathy and insulin resistance--hope for new therapeutic targetsTendinous disorders attributed to statins: a study on ninety-six spontaneous reports in the period 1990-2005 and review of the literature.Preservation of NO production by statins in the treatment of heart failureHyperlipidemia and statin use after allogeneic hematopoietic stem cell transplantation.Pleiotropic vasoprotective effects of statins: the chicken or the egg?
P2860
Q24242586-33836FAB-53FA-494E-B054-DA8D2472BCB0Q24245521-C28E76BB-EEFA-43C0-A4D5-9CDF3CFC0FFEQ24792926-D3B54D75-A4E9-486D-B8B0-F50F97D63615Q24793685-2473C099-72AB-4217-B0A1-11905FD55BA9Q24794301-055E6B0E-CB46-438D-B17F-F587DA9AD802Q24804153-4F035A7E-41B0-4A60-9281-0D8251C362AFQ26752168-DA70BFB7-49CB-490A-84F6-9C64AC3EA2BCQ27011330-421E7E05-F5CE-4E88-8DB5-CE6AD2337900Q28219321-1F6E1571-55ED-4048-9BA2-E75A1A7F179DQ28345569-CF40901C-2A9B-4692-A0BC-18241A25D6A5Q31920320-D620C14F-E3DD-4F68-9E3E-BB4BFE832154Q33146013-1CFD405D-FD00-4CA0-91F4-5BBFA6D87A4DQ33696612-CCFF5564-1FDE-43F0-A3B1-F0ACCEC0F6F4Q33826469-908D12A7-76B0-4AA0-8E3F-4DED7BAC06F9Q34045311-58F600DE-04E9-4C00-869C-47F5422B2CEDQ34142678-5200E50A-282C-4749-876A-149BBCA83B5FQ34239244-FE5AE4D3-317B-46F7-8E48-672DCD3EA285Q34468860-73405E1C-11D8-4F16-BB2A-AC8DE00B3D25Q34940824-AED9F2B6-CDE7-48B6-A26F-3A31CA2A5ABBQ34976738-D97382AF-D86B-4435-A1B4-190E8C8C907CQ35137013-DEFF3978-9791-4799-B494-A90D7DE37200Q35139244-3689B546-7A38-4FF6-8A39-DB71469BA866Q35170625-47259438-76DB-4713-8F28-32F2D46AA0BAQ35376786-C3A2632B-E840-4AA1-80C9-604FF2610EFBQ35551180-F924B029-37BE-40A0-AC43-B0DBF71E7038Q35804356-7186B3FC-DDD7-4231-B8B4-76FD1E9FEA77Q35952218-36297913-AC2D-4E8B-90A3-FE31565C7B8CQ36088044-6C027FF3-A3AA-4B4F-9067-C68C6AB56968Q36240108-6572C54F-D2E4-4F6A-953E-DC64E07C7103Q36337932-38FB5045-8141-4820-BB12-6F7D7A78270AQ36395695-885EE0A0-266B-4999-BA2F-C40131B6F08FQ36410601-C91932D3-7DED-4D36-A799-53BA044BC344Q36521906-63132C44-A124-40C5-B1D7-C71E165F4E7FQ36577189-7A3737F3-E012-46BB-9D23-8F63DD3FA64FQ36823012-C23B72D6-F05B-4B27-9505-A5A7ED8D1313Q36993722-5EE5F058-E72B-46DC-8CAE-5B3B2A4EDAF3Q37098879-18663F9A-D7BD-4899-82CB-AF9C19965143Q37121936-38CCD748-1AC9-459E-B44B-32BC73EDDFFFQ37247613-63712B74-A7AC-4BC8-9DD8-F6B0263E3E3FQ37403235-512869DD-4A8C-490D-AFB6-B9A7D6848EC9
P2860
Simvastatin reduces graft vessel disease and mortality after heart transplantation: a four-year randomized trial.
description
1997 nî lūn-bûn
@nan
1997 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
name
Simvastatin reduces graft vess ...... a four-year randomized trial.
@ast
Simvastatin reduces graft vess ...... a four-year randomized trial.
@en
Simvastatin reduces graft vess ...... a four-year randomized trial.
@nl
type
label
Simvastatin reduces graft vess ...... a four-year randomized trial.
@ast
Simvastatin reduces graft vess ...... a four-year randomized trial.
@en
Simvastatin reduces graft vess ...... a four-year randomized trial.
@nl
prefLabel
Simvastatin reduces graft vess ...... a four-year randomized trial.
@ast
Simvastatin reduces graft vess ...... a four-year randomized trial.
@en
Simvastatin reduces graft vess ...... a four-year randomized trial.
@nl
P2093
P356
P1433
P1476
Simvastatin reduces graft vess ...... a four-year randomized trial.
@en
P2093
Reichart B
Steinbeck G
von Scheidt W
P304
P356
10.1161/01.CIR.96.5.1398
P407
P577
1997-09-01T00:00:00Z